At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 160 enrolled
Drug / intervention
epidural bupivacaine 0.05% +5 moredrug
Likely dose
/hydromorphone 0.05mg/mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy
In Brief
A Phase 3 clinical trial evaluating epidural bupivacaine 0.05%, Liposomal bupivacaine, and 4 other interventions for Cystectomy. Completed, enrolled 160 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the difference between four different pain control methods in patients who will be having a cystectomy surgery (surgical removal of the bladder).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystectomy
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2020202120222023202420252026
Enrollment StartOct 2019
First PostedMar 2020
Primary CompletionDec 2021
Study CompletionDec 2021
TodayJul 2026
First PostedMar 9, 2020
Enrollment StartOct 22, 2019
Primary CompletionDec 23, 2021
Study CompletionDec 24, 2021
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 6.3 years ago
Interventions
epidural bupivacaine 0.05%drug
Mix of epidural bupivacaine 0.05% and hydromorphone 0.05mg/ml will be given using PCEA.
Liposomal bupivacainedrug
20 ml
bupivacaine 0.125%drug
40 mL
bupivacaine 0.5%drug
60 mL
/hydromorphone 0.05mg/mldrug
Mix of epidural bupivacaine 0.05% and hydromorphone 0.05mg/ml will be given using PCEA.
injectable salinedrug
40 mL